#Bristol Myers Squibb

Bristol Myers Squibb buys Nvidia AI system for drug discovery

Bristol Myers Squibb has acquired Nvidia's DGX SuperPOD based on the Vera Rubin architecture, becoming the first life sciences company to do so. The system will accelerate drug discovery and development through advanced AI capabilities.